Generic name: emtricitabine, sometimes also called FTC.
Brand names: Emtriva
Class: Individual NRTIs (nukes)
Very common (affecting at least 10 in every 100 people): Nausea, diarrhoea, headache, raised creatine kinase levels in the blood which can cause muscle pain and weakness.Common (affecting up to 10 in every 100 people): skin darkening especially in children, difficulty sleeping, abnormal dreams, dizziness, vomiting, stomach pain, rash, pain, weakness, low white blood cell count, increased triglycerides, bile or sugar in the blood, liver problems, pancreas problems.Uncommon (affecting up to 1 in every 100 people): Anaemia, swelling of the face, lips, tongue or throat.
200mg capsule.Take 200mg once a day.An oral solution (at a concentration of 10mg/ml) is available for those with difficulty swallowing the capsules or those with kidney problems.
Take with or without food.
*Last reviewed on 19/12/2016 Next review: 19/12/2019
Any questions? Email firstname.lastname@example.org Information included on this website was correct at the time of publication.
Data and image supplied by NAM.
Various people talk about their experiences of living with HIV.
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2018 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 314-320 Gray's Inn Road, London, WC1X 8DP.